表紙
企業レポート

世界のジェネリック医薬品業界における提携動向(2010年):企業ガイド

Partnering in the Global Generics Industry 2010: A guide to companies

発行 Espicom Business Intelligence 商品コード 135779
出版日 ページ情報 英文 472 Pages
納期: 即日から翌営業日
価格
こちらの商品の販売は終了いたしました。
Back to Top
世界のジェネリック医薬品業界における提携動向(2010年):企業ガイド Partnering in the Global Generics Industry 2010: A guide to companies
出版日: 2010年10月21日 ページ情報: 英文 472 Pages

当商品の販売は、2016年07月01日を持ちまして終了しました。

概要

当報告書では、世界のジェネリック医薬品市場におけるM&A候補や提携パートナーの特定に役立てられるよう、世界40ヶ国における中規模ジェネリック医薬品製造業者168社の各種企業データを国別に掲載し、概略下記の構成でお届けいたします。

掲載内容

  • 企業背景
    • 創業年
    • 業務内容
  • 製品
    • 代表製品など
  • 財務データ
    • 財務実績
    • 資金調達データ、など
  • 戦略的提携
    • マーケティング
    • 供給契約の詳細
  • 企業情報

掲載されている地域

  • アフリカ・中東
  • 欧州
  • 北米
  • 南米
目次
Product Code: 2199

Abstract

META Description

Identify merger, acquisition and partner candidates in the rapidly changing global generics market...

Consolidation and collaboration runs throughout the generic industry. Here' s just a taste of the acquisitions, controlling investments and deals reported recently...

  • URL Pharma acquire manufacturing assets of PharmPro
  • Luitpold Pharma acquires Pharmaforce
  • Hi-Tech Pharmacal acquires product line from Blaine Company
  • Aspen Pharmacare acquires Sigma' s pharmaceutical division
  • Sun Pharmaceuticals' long expected acquisition of Taro Pharmaceuticals
  • Sandoz acquires Ebewe Pharmaceuticals
  • GSK acquires Stiefel
  • Strides Arcolab acquires Ascent Pharmahealth
  • sanofi-aventis form Japanese joint venture with Nichi-Iko
  • Adcock-Ingram acquires Ghanaian manufacturer Ayrton
  • Cephalon acquires Mepha
  • Strategic partnering

In addition to outright purchase, strategic partnering or the acquisition of specific drug assets is on the rise as companies seek to bring lower costs and focus to their portfolios. With business cycles growing shorter and shorter, market entry is quicker, more reliable and less risky through acquisition and partnering.

The fundamental market drivers are sound

In addition to ongoing expansion, there are other drivers which are causing the generic companies to consider the future:

Over the next 5 years a number of blockbuster pharmaceutical products such as Lipitor, Cozaar, Lovenox, Plavix, Cymbalta and Seroquel will be losing patent protection. The number of biologics coming into the remit of generic companies is increasing, raising interest in companies with biosimilars production capability. The branded industry' s response

The branded industry continues to vigorously protect its IP and maximise the lifetime value of its products. While legal initiatives will remain a key weapon there will also be commercial responses such as issuing early branded generics, collaborative working with a limited number of generic producers, new formulations or combination products.

Identify new business opportunities and assess risk

For everyone needing to evaluate the generic industry' s competitive landscape, this thoroughly-researched and expanded 3rd Edition of Partnering in the Global Generics Industry 2010: A guide to companies (published October 2010) is essential reading. In 450 information-packed pages this completely revised edition references 168 generics companies operating in 40 markets around the world.

  • Africa/Middle East
  • EIPICo Egypt
  • Dexcel Pharma Israel
  • Taro Pharmaceutical Industries Israel
  • Hikma Jordan
  • Regal Pharmaceuticals Kenya
  • Tabuk Pharmaceutical Manufacturing Saudi Arabia
  • Adcock Ingram South Africa
  • Cipla Medpro South Africa
  • Asia/Pacific
  • Ascent Pharmahealth Australia
  • Australian Pharmaceutical Industries Australia
  • Hamilton Laboratories Australia
  • Sigma Pharmaceuticals Australia
  • Beximco Pharmaceuticals Bangladesh
  • China Pharma Holdings China
  • Alembic India
  • Alkem Laboratories India
  • Biocon India
  • Emcure Pharmaceuticals India
  • Gland Pharma India
  • Glenmark Pharmaceuticals India
  • Hetero Drugs India
  • Indoco Remedies India
  • JB Chemicals & Pharmaceuticals India
  • Jubilant Organosys India
  • Natco Pharma India
  • Orchid Chemicals & Pharmaceuticals India
  • Strides Arcolab India
  • Torrent Pharmaceuticals India
  • USV India
  • Kimia Indonesia
  • Nichi-iko Pharmaceutical Japan
  • Towa Pharmaceutical Japan
  • CCM Pharmaceuticals Malaysia
  • Inno Biologics Malaysia
  • CCL Pakistan
  • Dr Raza Pharma Pakistan
  • Epla Labs Pakistan
  • Highnoon Laboratories Pakistan
  • Abdi Ibrahim Turkey
  • Bilim Pharmaceuticals Turkey
  • EastPharma Turkey
  • Mustafa Nevzat Pharmaceuticals Turkey
  • Europe
  • Ebewe Pharma Austria
  • Sopharma Bulgaria
  • Unipharm Bulgaria
  • Belupo Croatia
  • Alternova Denmark
  • Orifarm Denmark
  • Biogaran France
  • Consilient Health Ireland
  • Reliance GeneMedix Ireland
  • Eurand Italy
  • Grindeks Latvia
  • Sanitas Lithuania
  • Hovione FarmaCiencia Portugal
  • Antibiotice Romania
  • Europharm Romania
  • Akrikhin Russia
  • Bryntsalov Russia
  • Erka Farm Russia
  • Farmacon Russia
  • Pharmstandard Russia
  • Veropharm Russia
  • Biotika Slovakia
  • Combino Pharm Spain
  • Invent Farma Group Spain
  • Laboratorios Cinfa Spain
  • Acino Pharma Switzerland
  • Azad Switzerland
  • Helvepharm Switzerland
  • Mepha Pharma Switzerland
  • Spirig Switzerland
  • Streuli Switzerland
  • Goldshield Group UK
  • Kent Pharmaceuticals UK
  • ProStrakan UK
  • Rosemont Pharmaceutical UK
  • North America
  • Labopharm Canada
  • Pharmascience Canada
  • Akorn USA
  • Alovgen USA
  • Amneal Pharmaceuticals USA
  • Amphastar Pharmaceuticals USA
  • Anchen Pharmaceuticals USA
  • APP Pharmaceuticals USA
  • Banner Pharmacaps USA
  • Bedford Laboratories USA
  • Bio-Nucleonics USA
  • Boca Pharmacal USA
  • Breckenridge Pharma USA
  • Caraco Pharmaceutical Laboratories USA
  • Carolina Medical Products Company USA
  • Cedar Pharmaceuticals USA
  • Cephazone Pharma USA
  • CorePharma USA
  • Cypress Pharmaceutical USA
  • Ferndale Laboratories USA
  • Fleming Pharmaceuticals USA
  • Fougera USA
  • G&W Laboratories USA
  • GeneraMedix USA
  • Hanford Manufacturing USA
  • Harmony Labs USA
  • Heritage Pharmaceuticals USA
  • Hi-Tech Pharmacal USA
  • Indicus Pharmaceuticals USA
  • InvaGen Pharmaceuticals USA
  • Kremers-Urban (KUDCo) USA
  • KV Pharmaceutical USA
  • KVK-Tech USA
  • Luitpold Pharmaceuticals USA
  • Lyne Laboratories USA
  • Mallinckrodt USA
  • Mikart USA
  • Neil Laboratories USA
  • Nephron Pharmaceuticals USA
  • Paddock Laboratories USA
  • Pharmaceutical Associates USA
  • PharmaForce USA
  • Prasco USA
  • Prometheus Laboratories USA
  • Roxane Laboratories USA
  • RxElite Holdings USA
  • Silarx Pharmaceuticals USA
  • Spear Pharmaceuticals USA
  • Stasun Pharmaceuticals USA
  • Stiefel USA
  • SuperGen USA
  • ThePharmaNetwork USA
  • Three Rivers Pharmaceuticals USA
  • Tris Pharma USA
  • URL Pharma USA
  • Upsher-Smith Laboratories USA
  • VersaPharm USA
  • Vista Pharmaceuticals USA
  • VistaPharm USA
  • X-GEN Pharmaceuticals USA
  • South America
  • Osmotica Pharmaceutical Argentina
  • Ache Brazil
  • Americano Brazil
  • Biolab Brazil
  • Cimed Brazil
  • Cristalia Brazil
  • EMS-Sigma Brazil
  • Eurofarma Brazil
  • LAFEPE Brazil
  • Libbs Farmaceutica Brazil
  • Medley Brazil
  • Prati-Donaduzzi Brazil
  • Andromaco Chile
  • Bestpharma Chile
  • Biosano Chile
  • Maver Chile
  • Mintlab Chile
  • Ecar Colombia
  • Genfar Colombia
  • La Sante Colombia
  • Lafrancol Colombia
  • Laboratorios Kendrick Mexico
  • Laboratorios Silanes Mexico
  • Farmindustria Peru
  • Induquimica Peru
  • Infarmasa Peru
  • Calox Internacional Venezuela
  • Cofasa Venezuela
  • Kimiceg Venezuela
  • Leti Venezuela
  • Meyer Venezuela

More Information...

Unbeatable coverage

For each company, where available or appropriate, the report provides...

BACKGROUND

A summary of the company' s foundation and main business interests

PRODUCT RANGE

Details of ANDAs approved or products represented

FINANCIAL

Financial performance or funding data

STRATEGIC ALLIANCES

Details of significant marketing and supply agreements

CONTACT INFORMATION

Use this report to...

  • Identify commercial partners
  • Understand the developing generic industry in key markets worldwide
  • Profile the competitive environment in the increasingly important medium-sized company sector
  • Seek out companies manufacturing/marketing similar product lines
  • Assess the investment potential of these developing companies

Table of Contents

Introduction

  • Companies in this report

Argentina

Osmotica Pharmaceutical

  • Background
  • Products
  • Contact Details

Australia

Ascent Pharmahealth

  • Background
  • Products
  • Financials
  • Major Developments
  • Contact Details

Australian Pharmaceutical Industries

  • Background
  • Financials
  • Major Developments
  • Contact Details

Hamilton Laboratories

  • Background
  • Products
  • Contact Details

Sigma Pharmaceuticals

  • Background
  • Products
  • Financials
  • Major Developments
  • Contact Details

Austria

Ebewe Pharma

  • Background
  • Products
  • Financials
  • Major Developments
  • Contact Details

Bangladesh

Beximco Pharmaceuticals

  • Background
  • Products
  • Financials
  • Major Developments
  • Contact Details

Brazil

Aché

  • Background
  • Products
  • Financials
  • Major Developments
  • Contact Details

Americano

  • Background
  • Products
  • Financials
  • Contact Details

Biolab

  • Background
  • Products
  • Financials
  • Contact Details

Cimed

  • Background
  • Products
  • Financials
  • Contact Details

Cristalia

  • Background
  • Products
  • Financials
  • Contact Details

EMS-Sigma

  • Background
  • Products
  • Financials
  • Contact Details

Eurofarma

  • Background
  • Major Developments
  • Contact Details

LAFEPE

  • Background
  • Products
  • Contact Details

Libbs Farmaceutica

  • Background
  • Products
  • Financials
  • Major Developments
  • Contact Details

Medley

  • Background
  • Products
  • Financials
  • Major Developments
  • Contact Details

Prati-Donaduzzi

  • Background
  • Products
  • Financials
  • Contact Details

Bulgaria

Sopharma

  • Background
  • Products
  • Financials
  • Contact Details

Unipharm

  • Background
  • Contact Details

Canada

Labopharm

  • Background
  • Products
  • Financials
  • Major Developments
  • Contact Details

Pharmascience

  • Background
  • Products
  • Major Developments
  • Contact Details

Chile

Andromaco

  • Background
  • Products
  • Financials
  • Major Developments
  • Contact Details

Bestpharma

  • Background
  • Products
  • Contact Details

Biosano

  • Background
  • Products
  • Financials
  • Contact Details

Maver

  • Background
  • Contact Details

Mintlab

  • Background
  • Contact Details

China

China Pharma Holdings

  • Background
  • Products
  • Financials
  • Contact Details

Colombia

Ecar

  • Background
  • Contact details

Genfar

  • Background
  • Contact Details

La Santé

  • Background
  • Contact Details

Lafrancol

  • Background
  • Contact Details

Croatia

Belupo

  • Background
  • Products
  • Contact Details

Denmark

Alternova

  • Background
  • Products
  • Contact Details

Orifarm

  • Background
  • Products
  • Contact Details

Egypt

EIPICo

  • Background
  • Products
  • Contact Details

France

Biogaran

  • Background
  • Contact Details

India

Alembic

  • Background
  • Products
  • Financials
  • Major Developments
  • Contact Details

Alkem Laboratories

  • Background
  • Products
  • Major Developments
  • Contact Details

Biocon

  • Background
  • Products
  • Financials
  • Major Developments
  • Contact Details

Emcure Pharmaceuticals

  • Background
  • Products
  • Major Developments
  • Contact Details

Gland Pharma

  • Background
  • Products
  • Contact Details

Glenmark Pharmaceuticals

  • Background
  • Products
  • Financials
  • Major Developments
  • Contact Details

Hetero Drugs

  • Background
  • Products
  • Major Developments
  • Contact Details

Indoco Remedies

  • Background
  • Products
  • Financials
  • Major Developments
  • Contact Details

JB Chemicals & Pharmaceuticals

  • Background
  • Products
  • Financials
  • Major Developments
  • Mergers, Acquisitions and Agreements
  • Contact Details

Jubilant Organosys

  • Background
  • Products
  • Financials
  • Major Developments
  • Contact Details

Natco Pharma

  • Background
  • Products
  • Financials
  • Major Developments
  • Contact Details

Orchid Chemicals & Pharmaceuticals

  • Background
  • Products
  • Financials
  • Major Developments
  • Contact Details

Strides Arcolab

  • Background
  • Products
  • Financials
  • Major Developments
  • Contact Details

Torrent Pharmaceuticals

  • Background
  • Products
  • Financials
  • Major Developments
  • Contact Details

USV

  • Background
  • Products
  • Contact Details

Indonesia

Kimia

  • Background
  • Contact Details

Ireland

Consilient Health

  • Background
  • Products
  • Contact Details

Reliance GeneMedix

  • Background
  • Products
  • Financials
  • Major Developments
  • Contact Details

Israel

Dexcel Pharma

  • Background
  • Products
  • Major Developments
  • Contact Details

Taro Pharmaceutical Industries

  • Background
  • Products
  • Financials
  • Major Developments
  • Contact Details

Italy

Eurand

  • Background
  • Products
  • Financials
  • Major Developments
  • Contact Details

Japan

Nichi-iko Pharmaceutical

  • Background
  • Financials
  • Major Developments
  • Contact Details

Towa Pharmaceutical

  • Background
  • Products
  • Financials
  • Major developments
  • Contact Details

Jordan

Hikma

  • Background
  • Products
  • Financials
  • Major Developments
  • Contact Details

Kenya

Regal Pharmaceuticals

  • Background
  • Products
  • Major Developments
  • Contact Details

Latvia

Grindeks

  • Background
  • Products
  • Financials
  • Major Developments
  • Contact Details

Lithuania

Sanitas

  • Background
  • Products
  • Financials
  • Major Developments
  • Contact Details

Malaysia

CCM Pharmaceuticals

  • Background
  • Products
  • Financials
  • Major Developments
  • Contact Details

Inno Biologics

  • Background
  • Products
  • Contact Details

Mexico

Laboratorios Kendrick

  • Background
  • Contact Details

Laboratorios Silanes

  • Background
  • Contact Details

Pakistan

CCL

  • Background
  • Contact Details

Dr. Raza Pharma

  • Background
  • Contact Details

Epla Labs

  • Background
  • Products
  • Contact Details

Highnoon Laboratories

  • Background
  • Products
  • Financials
  • Contact Details

Peru

Farmindustria

  • Background
  • Contact Details

Induquimica

  • Background
  • Products
  • Contact Details

Infarmasa

  • Background
  • Financials
  • Contact Details

Portugal

Hovione FarmaCiencia

  • Background
  • Products
  • Financials
  • Major Developments
  • Contact Details

Romania

Antibiotice

  • Background
  • Products
  • Financials
  • Contact Details

Europharm

  • Background
  • Contact Details

Russia

Akrikhin

  • Background
  • Products
  • Financials
  • Contact Details

Bryntsalov A

  • Background
  • Contact Details

Erka Farm

  • Background

Farmacon

  • Background
  • Contact Details

Pharmstandard

  • Background
  • Products
  • Financials
  • Major Developments
  • Contact Details

Veropharm

  • Background
  • Financials
  • Contact Details

Saudi Arabia

Tabuk Pharmaceutical Manufacturing

  • Background
  • Contact Details

Slovakia

Biotika

  • Background
  • Financials
  • Contact Details

South Africa

Adcock Ingram

  • Background
  • Products
  • Financials
  • Major Developments
  • Contact Details

Cipla Medpro

  • Background
  • Products
  • Financials
  • Major Developments
  • Contact Details

Spain

Combino Pharm

  • Background
  • Products
  • Major Developments
  • Contact Details

Invent Farma Group

  • Background
  • Products
  • Major Developments
  • Contact Details

Laboratorios Cinfa

  • Background
  • Products
  • Financials
  • Major Developments
  • Contact Details

Switzerland

Acino Pharma

  • Background
  • Products
  • Financials
  • Major Developments
  • Contact Details

Azad

  • Background
  • Products
  • Major Developments
  • Contact Details

Helvepharm

  • Background
  • Contact Details

Mepha Pharma

  • Background
  • Financials
  • Contact Details

Spirig

  • Background
  • Products
  • Financials
  • Contact Details

Streuli

  • Background
  • Contact Details

Turkey

Abdi Ibrahim

  • Background
  • Products
  • Major Developments
  • Contact Details

Bilim Pharmaceuticals

  • Background
  • Products
  • Contact Details

EastPharma

  • Background
  • Products
  • Financials
  • Contact Details

Mustafa Nevzat Pharmaceuticals

  • Background
  • Products
  • Major Developments
  • Contact Details

UK

Goldshield Group

  • Background
  • Products
  • Financials
  • Major Developments
  • Contact Details

Kent Pharmaceuticals

  • Background
  • Financials
  • Major Developments
  • Contact Details

ProStrakan

  • Background
  • Products
  • Financials
  • Major Developments
  • Contact Details

Rosemont Pharmaceutical

  • Background
  • Products
  • Financials
  • Major Developments
  • Contact Details

USA

Akorn

  • Background
  • Products
  • Financials
  • Major Developments
  • Contact Details

Alovgen

  • Background
  • Products
  • Major Developments
  • Contact Details

Amneal Pharmaceuticals

  • Background
  • Products
  • Major Developments
  • Contact Details

Amphastar Pharmaceuticals

  • Background
  • Products
  • Major Developments
  • Contact Details

Anchen Pharmaceuticals

  • Background
  • Products
  • Major Developments
  • Contact Details

APP Pharmaceuticals

  • Background
  • Products
  • Major Developments
  • Contact Details

Banner Pharmacaps

  • Background
  • Products
  • Major Developments
  • Contact Details

Bedford Laboratories

  • Background
  • Products
  • Major Developments
  • Contact Details

Bio-Nucleonics

  • Background
  • Products
  • Contact Details

Boca Pharmacal

  • Background
  • Products
  • Contact Details

Breckenridge Pharma

  • Background
  • Products
  • Major Developments
  • Contact Details

Caraco Pharmaceutical Laboratories

  • Background
  • Products
  • Financials
  • Major Developments
  • Contact Details

Carolina Medical Products Company

  • Background
  • Products
  • Contact Details

Cedar Pharmaceuticals

  • Background
  • Products
  • Contact Details

Cephazone Pharma

  • Background
  • Products
  • Contact Details

CorePharma

  • Background
  • Products
  • Major Developments
  • Contact Details

Cypress Pharmaceutical

  • Background
  • Products
  • Major Developments
  • Contact Details

Ferndale Laboratories

  • Background
  • Products
  • Major Developments
  • Contact Details

Fleming Pharmaceuticals

  • Background
  • Products
  • Contact Details

Fougera

  • Background
  • Products
  • Major Developments
  • Contact Details

G&W Laboratories

  • Background
  • Products
  • Contact Details

GeneraMedix

  • Background
  • Products
  • Major Developments
  • Contact Details

Hanford Manufacturing

  • Background
  • Products
  • Major Developments
  • Contact Details

Harmony Labs

  • Background
  • Products
  • Contact Details

Heritage Pharmaceuticals

  • Background
  • Products
  • Major Developments
  • Contact Details

Hi-Tech Pharmacal

  • Background
  • Products
  • Financials
  • Major Developments
  • Contact Details

Indicus Pharmaceuticals

  • Background
  • Products
  • Contact Details

InvaGen Pharmaceuticals

  • Background
  • Products
  • Major Developments
  • Contact Details

Kremers-Urban (KUDCo)

  • Background
  • Products
  • Major Developments
  • Contact Details

KV Pharmaceutical

  • Background
  • Products
  • Financials
  • Major Developments
  • Contact Details

KVK-Tech

  • Background
  • Products
  • Contact Details

Luitpold Pharmaceuticals

  • Background
  • Products
  • Major Developments
  • Contact Details

Lyne Laboratories

  • Background
  • Products
  • Contact Details

Mallinckrodt

  • Background
  • Products
  • Major Developments
  • Contact Details

Mikart

  • Background
  • Products
  • Contact Details

Neil Laboratories

  • Background
  • Products
  • Contact Details

Nephron Pharmaceuticals

  • Background
  • Products
  • Contact Details

Paddock Laboratories

  • Background
  • Products
  • Major Developments
  • Contact Details

Pharmaceutical Associates

  • Background
  • Products
  • Contact Details

PharmaForce

  • Background
  • Products
  • Major Developments
  • Contact Details

Prasco

  • Background
  • Products
  • Major Developments
  • Contact Details

Prometheus Laboratories

  • Background
  • Products
  • Contact Details

Roxane Laboratories

  • Background
  • Products
  • Major Developments
  • Contact Details

RxElite Holdings

  • Background
  • Products
  • Major Developments
  • Contact Details

Silarx Pharmaceuticals

  • Background
  • Products
  • Contact Details

Spear Pharmaceuticals

  • Background
  • Products
  • Contact Details

Stason Pharmaceuticals

  • Background
  • Products
  • Major Developments
  • Contact Details

Stiefel

  • Background
  • Products
  • Major Developments
  • Contact Details

SuperGen

  • Background
  • Products
  • Financials
  • Major Developments
  • Contact Details

ThePharmaNetwork

  • Background
  • Products
  • Contact Details

Three Rivers Pharmaceuticals

  • Background
  • Products
  • Major Developments
  • Contact Details

Tris Pharma

  • Background
  • Major Developments
  • Contact Details

URL Pharma

  • Background
  • Products
  • Major Developments
  • Contact Details

Upsher-Smith Laboratories

  • Background
  • Products
  • Major Developments
  • Contact Details

VersaPharm

  • Background
  • Products
  • Contact Details

Vista Pharmaceuticals

  • Background
  • Products
  • Contact Details

VistaPharm

  • Background
  • Products
  • Contact Details

X-GEN Pharmaceuticals

  • Background
  • Products
  • Major Developments
  • Contact Details

Venezuela

Calox Internacional

  • Background
  • Contact Details

Cofasa

  • Background
  • Contact Details

Kimiceg

  • Background
  • Contact Details

Leti

  • Background
  • Contact Details

Meyer

  • Background
  • Contact Details

INDEX OF TABLES

  • Companies in the report by country of origin
  • Osmotica Pharmaceutical ANDA Approvals, 2002 - June 2010
  • Ascent Pharmahealth: consolidated fiscal year results in A$000s
  • Australian Pharmaceutical Industries: consolidated fiscal year results in A$000s
  • Sigma Pharmaceuticals: fiscal year results in A$ millions
  • Ebewe Pharma ANDA Approvals, 2002-09
  • Beximco Pharmaceuticals: fiscal year results, in BDT000s
  • Cimed: Sales, 2004 - 2007
  • LAFEPE: Product Lines
  • Libbs Farmaceutica: Pharmaceutical Sales, 2000 - 2006
  • Medley: International Agreements, 1992 - 2005
  • Medley: pharmacy sales by value in US$ millions
  • Medley: generic sales by volume
  • Sopharma: Financial Data, in Leva 000s
  • Labopharm: fiscal year results, in C$000s
  • Andromaco: Financial Results, 2000 - 2007
  • Biosano: Product Portfolio
  • Alembic: manufacturing facilities
  • Alembic ANDA Approvals, 2002 - June 2010
  • Alembic: Financial Results, in Rs millions
  • Alkem Laboratories ANDA Approvals, 2002 - June 2010
  • Biocon: Consolidated Financial Results, in Rs millions
  • Emcure Pharmaceuticals ANDA Approvals, 2002 - June 2010
  • Gland Pharma ANDA Approvals, 2002 - June 2010
  • Glenmark Pharmaceuticals / Glenmark Generics ANDA Approvals, January 2002 - June 2010
  • Glenmark Pharmaceuticals: consolidated financial results in Rs millions
  • Glenmark Pharmaceuticals: consolidated financial results by business in Rs millions
  • Hetero Drugs ANDA Approvals, 2002 - June 2010
  • Indoco Remedies: Financial Results (Rs millions)
  • Indoco Remedies: Financial Results (US$ millions)
  • Unique Pharmaceutical Laboratories ANDA Approvals, 2002 - June 2010
  • JB Chemicals & Pharmaceuticals: Financial Results, in Rs millions
  • JB Chemicals & Pharmaceuticals: Financial Results, in US$ millions
  • Trigen Laboratories / Cadista Pharmaceuticals / Jubilant Pharmaceuticals ANDA Approvals, January 2002 June 2010
  • Jubilant Organosys: standalone financial results, in Rs millions
  • Natco Pharma ANDA Approvals, January 2002 - June 2010
  • Natco Pharma: standalone financial results in Rs millions
  • Orchid Healthcare ANDA Approvals, January 2002 - June 2010
  • Orchid Chemicals & Pharmaceuticals: fiscal year results in Rs millions
  • Strides Arcolab ANDA Approvals, January 2002 - June 2010
  • Akorn-Strides ANDA Approvals, January 2002 - June 2010
  • Sagent-Strides ANDA Approvals, January 2002 - June 2010
  • Strides Arcolab: consolidated fiscal year results in Rs millions
  • Torrent Pharmaceuticals ANDA Approvals, January 2002 - June 2010
  • Torrent Pharmaceuticals: consolidated financial results, in Rs millions
  • Reliance GeneMedix: financial results, in euro 000s
  • Dexcel ANDA Approvals, January 2002 - June 2010
  • Taro Pharmaceutical Industries ANDA Approvals, January 2002 - June 2010
  • Taro Pharmaceutical Industries: financial results, in US$000s
  • Taro Pharmaceutical Industries: sales by location, in US$000s
  • Taro Pharmaceutical Industries: preliminary financial results, in US$000s
  • Eurand ANDA Approvals, January 2002 - June 2010
  • Eurand: consolidated financial results, in euro 000s
  • Nichi-Iko: Medium Term Business Plan Goals (¥ millions)
  • Towa Pharmaceutical: Fiscal Year Sales, in yen millions
  • Hikma Pharmaceuticals ANDA Approvals, January 2002 - June 2010
  • West-Ward ANDA Approvals, January 2002 - June 2010
  • Hikma: financial results, in US$000s
  • Hikma: financial results by region, in US$000s
  • Grindeks Group: financial results, in LVL000s
  • Grindeks Group: sales by location, in LVL000s
  • Sanitas: Group Financial Results, in LTL000s
  • Sanitas: Selected Financial Results by Region, in LTL000s
  • CCM: Group Financial Results, in RM000s
  • Antibiotice: Financial Results, 2002 - 2007
  • Pharmstandard: production by facility, 2008
  • Pharmstandard: financial results, 2004 - 2008 (R millions)
  • Pharmstandard: pharmaceutical sales, 2007 - 2008
  • Pharmstandard: top 10 OTCs, 2007 - 2008
  • Adcock Ingram: Fiscal Year Results, in R000s
  • Cipla Medpro: Group Financial Results (R000s)
  • EastPharma: Consolidated Financial Results, in US$000s
  • Goldshield: Financial Results, 2003 - 2009 (£000s)
  • Goldshield: Sales by Region, 2006 - 2009 (£000s)
  • Goldshield: Selected Sales by Segment, 2006 - 2009 (£000s)
  • ProStrakan: Consolidated Financial Results, in £ millions
  • ProStrakan: Selected Consolidated Financial Results by Destination, in £ millions
  • Akorn ANDA Approvals, 2002 - June 2010
  • Akorn-Strides ANDA Approvals, 2002 - June 2010
  • Akorn: Financial Results in US$000s
  • Amneal Pharmaceuticals ANDA Approvals, 2006 - June 2010
  • Interpharm ANDA Approvals, 2002 - 2008
  • Amphastar Pharmaceuticals ANDA Approvals, 2002 - June 2010
  • International Medication Systems ANDA Approvals, 2002 - June 2010
  • Anchen Pharmaceuticals ANDA Approvals, 2002 - June 2010
  • American Pharmaceutical Partners ANDA Approvals, 2002 - 2006
  • Abraxis ANDA Approvals, 2006 - 2008
  • APP Pharmaceuticals ANDA Approvals, 2008 - June 2010
  • Banner Pharmacaps ANDA Approvals, 2002 - June 2010
  • Bedford Laboratories ANDA Approvals, 2002 - June 2010
  • Ben Venue Laboratories ANDA Approvals, 2002 - June 2010
  • Bio-Nucleonics ANDA Approvals, 2002 - June 2010
  • Boca Pharmacal ANDA Approvals, 2002 - June 2010
  • Breckenridge Pharmaceutical ANDA Approvals, 2002 - June 2010
  • Caraco Pharmaceutical Laboratories ANDA Approvals, 2002 - June 2010
  • Caraco Pharmaceutical Laboratories: Financial Results, FY2005 - FY2009 (US$000s)
  • Carolina Medical Products ANDA Approvals, 2002 - June 2010
  • Cedar Pharmaceuticals ANDA Approvals, 2002 - June 2010
  • Cephazone Pharma ANDA Approvals, 2002 - June 2010
  • CorePharma ANDA Approvals, 2002 - June 2010
  • Cypress Pharmaceutical ANDA Approvals, 2002 - June 2010
  • Ferndale Laboratories ANDA Approvals, 2002 - June 2010
  • Fleming & Company Pharmaceuticals ANDA Approvals, 2002 - June 2010
  • Altana ANDA Approvals, 2002 - June 2010
  • Nycomed ANDA Approvals, 2002 - June 2010
  • G&W Laboratories ANDA Approvals, 2002 - June 2010
  • GeneraMedix ANDA Approvals, 2002 - June 2010
  • Hanford Manufacturing ANDA Approvals, 2002 - June 2010
  • Harmony Labs ANDA Approvals, 2002 - June 2010
  • Hi-Tech Pharmacal ANDA Approvals, 2002 - June 2010
  • Hi-Tech Pharmacal: Consolidated Fiscal Year Results, in US$ millions)
  • Indicus Pharmaceuticals ANDA Approvals, 2002 - June 2010
  • InvaGen Pharmaceuticals ANDA Approvals, 2002 - June 2010
  • KUDCo ANDA Approvals, 2002 - June 2010
  • KV Pharmaceuticals / Ethex ANDA Approvals, 2002 - June 2010
  • KV Pharmaceutical: Financial Results, in US$ millions
  • KVK-Tech ANDA Approvals, 2002 - June 2010
  • Luitpold Pharmaceuticals ANDA Approvals, 2002 - June 2010
  • Lyne Laboratories ANDA Approvals, 2002 - June 2010
  • Mallinckrodt ANDA Approvals, 20002 - June 2010
  • Mikart ANDA Approvals, 2002 - June 2010
  • Neil Laboratories ANDA Approvals, 2002 - June 2010
  • Nephron Pharmaceuticals ANDA Approvals, 2002 - June 2010
  • Paddock Laboratories ANDA Approvals, 2002 - June 2010
  • Pharmaceutical Associates ANDA Approvals, 2002 - June 2010
  • PharmaForce ANDA Approvals, 2002 - June 2010
  • Prometheus Laboratories ANDA Approvals, 2002 - June 2010
  • Roxane Laboratories ANDA Approvals, 2002 - June 2010
  • RxElite ANDA Approvals, 2002 - June 2010
  • Silarx Pharmaceuticals ANDA Approvals, 2002 - June 2010
  • Spear Pharmaceuticals ANDA Approvals, 2002 - June 2010
  • Stason Pharmaceuticals ANDA Approvals, 2002 - June 2010
  • Stiefel ANDA Approvals, 2002 - June 2010
  • SuperGen ANDA Approvals, 2002 - June 2010
  • SuperGen: Financial Results, in US$ millions
  • ThePharmaNetwork ANDA Approvals, 2002 - June 2010
  • Three Rivers ANDA Approvals, 2002 - June 2010
  • Mutual Pharmaceutical Company ANDA Approvals, 2002 - June 2010
  • Upsher-Smith Laboratories ANDA Approvals, 2002 - June 2010
  • VersaPharm ANDA Approvals, 2002 - June 2010
  • Covenant Pharma ANDA Approvals, 2002 - June 2010
  • Vista Pharmaceuticals ANDA Approvals, 2002 - June 2010
  • VistaPharm ANDA Approvals, 2002 - June 2010
  • X-GEN Pharmaceuticals ANDA Approvals, 2002 - June 2010
Back to Top